Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Daratumumab

Fatal pneumonia and neutropenic sepsis: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Essmann S, et al. Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation. Oncology Research and Treatment 42 (Suppl. 4): 190, Oct 2019. Available from: URL: http://doi.org/10.1159/000502425 [abstract] Essmann S, et al. Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation. Oncology Research and Treatment 42 (Suppl. 4): 190, Oct 2019. Available from: URL: http://​doi.​org/​10.​1159/​000502425 [abstract]
Metadaten
Titel
Daratumumab
Fatal pneumonia and neutropenic sepsis: 2 case reports
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33141-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antineoplastics

Case report

Empagliflozin

Case report

Lenvatinib